1-3 of 3
Noridza Rivera
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Check this checkpoint inhibitor in lymphoma

Clinical Trials & Observations
Fernando Cabanillas, Noridza Rivera
Journal: Blood
Blood (2017) 130 (3): 234–235.
https://doi.org/10.1182/blood-2017-05-786293
Published: 2017
Journal Articles

Clinically Discordant Indolent Lymphomas: A Subset of Indolent NHLs with a Less Favorable Prognosis and Propensity to Transform

Fernando Cabanillas, MD, Noridza Rivera, MD, Orestes Pavia, MD, Wandaly I. Pardo, MD, Margarita Bruno, MD
Journal: Blood
Blood (2015) 126 (23): 1497.
https://doi.org/10.1182/blood.V126.23.1497.1497
Published: 2015
Journal Articles

The Pretreatment Absolute Lymphocyte Count (ALC), but Not the Absolute Monocyte Count (AMC) or ALC/AMC Ratio, Is an Independent Prognostic Factor in Aggressive Non-Hodgkin Lymphoma (aNHL)

Noridza Rivera-Rodriguez, MD, Fernando Cabanillas, MD, Carlos Montalban, Jose Francisco Tomas, MD, María José Terol, MD, PhD, Armando López-Guillermo, MD, Wandaly I. Pardo, MD, Orestes A. Pavia, MD, Margarita Bruno, MD, Karen Janice Santiago, Pablo Guisado-Vasco, MD, PhD, Angel Ruedas, MD, Raquel de Oña, Silvia Solorzano, Ana Isabel Teruel, MD, Laura Garcia-Sanchis, Jordina Rovira, MD, Ivan Dlouhy
Journal: Blood
Blood (2012) 120 (21): 1596.
https://doi.org/10.1182/blood.V120.21.1596.1596
Published: 2012